More serious risks include pancreatitis, gallbladder disease, and potential thyroid C-cell tumors (observed in rodent studies)

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people, Yosei Medical Journal (2006) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Ozempic (semaglutide) injection prescribing information, Food and Drug Administration (2023) Phentermine hydrochloride tablets prescribing information, Food and Drug Administration (2017) Semaglutide, StatPearls (2024) Three- and six-month efficacy and safety of phentermine in a Mexican obese population, International Journal of Clinical Pharmacology and Therapeutics (2021) Topiramate and phentermine, StatPearls (2023) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Ipamorelin 2mg Selective growth hormone secretagogue
Symptoms include shakiness, sweating, confusion, rapid heartbeat, and extreme hunger
Treating obesity in silo with a product and not addressing whole health results in short-lived results with continued risks and complications of comorbidities